Crude trades near $50/bbl after decline in U.S. drilling

Must Read

OilNOW
OilNOW
OilNOW is an online-based Information and Resource Centre

(Bloomberg) — Oil traded near $50/bbl in New York, close to a three-month high, as a further reduction in U.S. drilling added to signs the global crude surplus is abating.

WTI futures slipped 0.5% after advancing 5.1% last week. Rigs targeting crude fell by seven to 749, according to data Friday from Baker Hughes. Drillers haven’t added any new machines during the past five weeks, capping in August the first monthly drop since May 2016. The third hurricane this month is tracking toward the Caribbean and strengthening along the way.

While oil has rebounded this month and pushed above $50/bbl last week, prices have struggled to hold at those levels this year as rising U.S. output stifles supply curbs led by OPEC. However, insufficient new investment in production is stoking the risk of tighter supply, according to the IEA, which last week raised its 2017 demand-growth forecast.

“The U.S. oil-rig count, a key indicator for trader sentiment, exhibited a rather large weekly decline,” said analysts at consultants JBC Energy in Vienna. “At least in the short term, this dynamic should help protect the downside to crude prices. The more pressing question may be how much higher prices can climb before the gravitational forces of global supply and demand can start to form an upper limit.”

WTI for October delivery declined $0.26 to $49.63/bbl on the New York Mercantile Exchange. On Sept. 14, it reached $50.50, the highest since May 25. Total volume traded was in line with the 100-day average.

Brent for November settlement also fell $0.26 to $55.36/bbl on the ICE Futures Europe exchange. Prices rose 3.4% last week. Brent crude traded at a premium of $5.24 to November WTI.

The U.S. rig count shrank in all four of the nation’s biggest oil basins last week, with Texas’s Eagle Ford and Permian regions leading the decline, data from Baker Hughes showed. American crude output has averaged about 9.23 MMbpd this year, according to government figures.

- ADVERTISEMENT -
spot_img

Partnered Events

Latest News

SpikImm Announces the Signature of an Exclusive License Option and Collaboration Agreement With SATT Conectus for the Development of a Prophylactic Treatment Against the...

PARIS--(BUSINESS WIRE)--SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated...

More Articles Like This